IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 58 filers reported holding IRADIMED CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,509 | -8.3% | 574,912 | -1.3% | 0.04% | +7.5% |
| Q2 2023 | $27,804 | +21.7% | 582,412 | +0.3% | 0.04% | +33.3% |
| Q1 2023 | $22,847 | +35.9% | 580,612 | -2.3% | 0.03% | +30.4% |
| Q4 2022 | $16,813 | -99.9% | 594,312 | -5.1% | 0.02% | -14.8% |
| Q3 2022 | $18,833,000 | -17.5% | 626,512 | -6.8% | 0.03% | 0.0% |
| Q2 2022 | $22,827,000 | -24.4% | 672,578 | -0.1% | 0.03% | -22.9% |
| Q1 2022 | $30,191,000 | -5.8% | 673,312 | -2.9% | 0.04% | -12.5% |
| Q4 2021 | $32,038,000 | +35.7% | 693,312 | -1.3% | 0.04% | +33.3% |
| Q3 2021 | $23,604,000 | +14.3% | 702,712 | +0.1% | 0.03% | +15.4% |
| Q2 2021 | $20,655,000 | +10.8% | 702,312 | -2.9% | 0.03% | +13.0% |
| Q1 2021 | $18,648,000 | +10.8% | 723,614 | -2.0% | 0.02% | +27.8% |
| Q4 2020 | $16,830,000 | +8.6% | 738,157 | +1.9% | 0.02% | +20.0% |
| Q3 2020 | $15,491,000 | -2.8% | 724,557 | +5.6% | 0.02% | +7.1% |
| Q2 2020 | $15,930,000 | +19.2% | 686,357 | +9.6% | 0.01% | +7.7% |
| Q1 2020 | $13,368,000 | +7.0% | 626,157 | +17.2% | 0.01% | +30.0% |
| Q4 2019 | $12,494,000 | +42.5% | 534,368 | +28.1% | 0.01% | +42.9% |
| Q3 2019 | $8,767,000 | +18.0% | 417,100 | +14.8% | 0.01% | 0.0% |
| Q2 2019 | $7,432,000 | -23.6% | 363,400 | +5.0% | 0.01% | -22.2% |
| Q1 2019 | $9,725,000 | +24.1% | 346,200 | +8.0% | 0.01% | 0.0% |
| Q4 2018 | $7,839,000 | +6.2% | 320,500 | +61.3% | 0.01% | +12.5% |
| Q3 2018 | $7,382,000 | +130.5% | 198,700 | +16.4% | 0.01% | +300.0% |
| Q2 2018 | $3,202,000 | +315.8% | 170,658 | +219.2% | 0.00% | +100.0% |
| Q1 2018 | $770,000 | +6.4% | 53,458 | +11.9% | 0.00% | 0.0% |
| Q4 2017 | $724,000 | +373.2% | 47,770 | +200.4% | 0.00% | – |
| Q3 2017 | $153,000 | -7.8% | 15,900 | -14.6% | 0.00% | – |
| Q1 2017 | $166,000 | -43.2% | 18,618 | -29.2% | 0.00% | – |
| Q4 2016 | $292,000 | -62.6% | 26,300 | -42.7% | 0.00% | -100.0% |
| Q3 2016 | $780,000 | – | 45,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 140,752 | $3,290,000 | 3.17% |
| RK Capital | 222,914 | $5,212,000 | 1.95% |
| Nine Ten Capital Management LLC | 130,272 | $3,046,000 | 0.76% |
| Parkman Healthcare Partners LLC | 93,500 | $2,186,000 | 0.63% |
| Ranger Investment Management | 244,963 | $5,727,000 | 0.38% |
| CADENCE CAPITAL MANAGEMENT LLC | 107,043 | $2,503,000 | 0.27% |
| ALGERT GLOBAL LLC | 29,652 | $693,000 | 0.21% |
| Mondrian Investment Partners LTD | 163,939 | $3,833,000 | 0.10% |
| NAVELLIER & ASSOCIATES INC | 20,800 | $486,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 56,811 | $1,328,000 | 0.04% |